Using a human α-synuclein A30P transgenic mouse model crossed with the GBA mutant, Taguchi et al. found that an increased level of glucosylsphingosine is correlated with the extent of α-synuclein aggregation, and thus GBA dysfunction is closely associated with the increased risk for PD [141,142]. Here, GBA1 is linked to Parkinson disease.